TY - JOUR T1 - Can we predict the outcome for people with patellofemoral pain? A systematic review on prognostic factors and treatment effect modifiers JF - British Journal of Sports Medicine JO - Br J Sports Med SP - 1650 LP - 1660 DO - 10.1136/bjsports-2016-096545 VL - 51 IS - 23 AU - M Matthews AU - M S Rathleff AU - A Claus AU - T McPoil AU - R Nee AU - K Crossley AU - B Vicenzino Y1 - 2017/12/01 UR - http://bjsm.bmj.com/content/51/23/1650.abstract N2 - Background Patellofemoral pain (PFP) is a multifactorial and often persistent knee condition. One strategy to enhance patient outcomes is using clinically assessable patient characteristics to predict the outcome and match a specific treatment to an individual.Aim A systematic review was conducted to determine which baseline patient characteristics were (1) associated with patient outcome (prognosis); or (2) modified patient outcome from a specific treatment (treatment effect modifiers).Methods 6 electronic databases were searched (July 2016) for studies evaluating the association between those with PFP, their characteristics and outcome. All studies were appraised using the Epidemiological Appraisal Instrument. Studies that aimed to identify treatment effect modifiers underwent a checklist for methodological quality.Results The 24 included studies evaluated 180 participant characteristics. 12 studies investigated prognosis, and 12 studies investigated potential treatment effect modifiers. Important methodological limitations were identified. Some prognostic studies used a retrospective design. Studies aiming to identify treatment effect modifiers often analysed too many variables for the limiting sample size and typically failed to use a control or comparator treatment group. 16 factors were reported to be associated with a poor outcome, with longer duration of symptoms the most reported (>4 months). Preliminary evidence suggests increased midfoot mobility may predict those who have a successful outcome to foot orthoses.Conclusions Current evidence can identify those with increased risk of a poor outcome, but methodological limitations make it difficult to predict the outcome after one specific treatment compared with another. Adequately designed randomised trials are needed to identify treatment effect modifiers. ER -